Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Reduction of secondary ischemic stroke risk following an initial stroke is an important goal. The 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack assembles opportunities for up to 80% secondary stroke reduction. Homocysteine reduction was not included in the recommend...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Craig, Wang, Jianhua, Jiang, Hong, Elias, Merrill F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559895/
https://www.ncbi.nlm.nih.gov/pubmed/37810545
http://dx.doi.org/10.2147/PGPM.S426421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559895/
https://www.ncbi.nlm.nih.gov/pubmed/37810545
http://dx.doi.org/10.2147/PGPM.S426421

Ejemplares similares